Skip to main content
Top
Published in: European Radiology 5/2019

01-05-2019 | Neuro

Validation of overestimation ratio and TL-SVS as imaging biomarker of cardioembolic stroke and time from onset to MRI

Authors: Romain Bourcier, Laurence Legrand, Sébastien Soize, Julien Labreuche, Marine Beaumont, Hubert Desal, Imad Derraz, Serge Bracard, Catherine Oppenheim, Olivier Naggara, on behalf of the THRACE investigators

Published in: European Radiology | Issue 5/2019

Login to get access

Abstract

Objective

We aimed to determine in the “THRACE” trial, the clinical and MRI technical parameters associated with the two-layered susceptibility vessel sign (TL-SVS) and the overestimation ratio (overR).

Materials and methods

Patients with pre-treatment brain gradient echo (GRE) sequence and an etiological work-up were identified. Two readers reviewed TL-SVS, i.e., a SVS with a linear low-intense signal core surrounded by a higher intensity and measured the overR as the width of SVS divided by the width of the artery. Binomial and ordinal logistic regression respectively tested the association between TL-SVS and quartiles of overR with patient characteristics, cardioembolic stroke (CES), time from onset to imaging, and GRE sequence parameters (inter slice gap, slice thickness, echo time, flip angle, voxel size, and field strength).

Results

Among 258 included patients, 102 patients were examined by 3 Tesla MRI and 156 by 1.5 Tesla MRI. Intra- and inter-reader agreements for quartiles of overR and TL-SVS were good to excellent. The median overR was 1.59 (IQR, 1.30 to 1.86). TL-SVS was present in 101 patients (39.2%, 95%CI, 33.1 to 45.1%). In multivariate analysis, only CES was associated with overR quartiles (OR, 1.83; 95%CI, 1.11 to 2.99), and every 60 min increase from onset to MRI time was associated with TL-SVS (OR, 1.72; 95%CI, 1.10 to 2.67). MRI technical parameters were statistically associated with neither overR nor TL-SVS.

Conclusion

Independent of GRE sequence parameters, an increased overR was associated to CES, while the TL-SVS is independently related to a longer time from onset to MRI.

Key Points

• An imaging biomarker would be useful to predict the etiology of stroke in order to adapt secondary prevention of stroke.
• The two-layered susceptibility vessel sign and the overestimation ratio are paramagnetic effect derived markers that vary according to the MRI machines and sequence parameters.
• Independent of sequence parameters, an increased overestimation ratio was associated to cardioembolic stroke, while the two-layered susceptibility vessel sign is independently related to a longer time from onset to MRI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Goldstein LB, Jones MR, Matchar DB et al (2001) Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke 32:1091–1098CrossRef Goldstein LB, Jones MR, Matchar DB et al (2001) Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke 32:1091–1098CrossRef
2.
go back to reference Brinjikji W, Duffy S, Burrows A et al (2016) Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review. J Neurointerv Surg 9:529–534 Brinjikji W, Duffy S, Burrows A et al (2016) Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review. J Neurointerv Surg 9:529–534
3.
4.
go back to reference Boeckh-Behrens T, Schubert M, Förschler A et al (2016) The impact of histological clot composition in embolic stroke. Clin Neuroradiol 26:189–197CrossRef Boeckh-Behrens T, Schubert M, Förschler A et al (2016) The impact of histological clot composition in embolic stroke. Clin Neuroradiol 26:189–197CrossRef
5.
go back to reference Kim SK, Yoon W, Heo TW, Park MS, Kang HK (2015) Negative susceptibility vessel sign and underlying intracranial atherosclerotic stenosis in acute middle cerebral artery occlusion. AJNR Am J Neuroradiol 36:1266–1271CrossRefPubMed Kim SK, Yoon W, Heo TW, Park MS, Kang HK (2015) Negative susceptibility vessel sign and underlying intracranial atherosclerotic stenosis in acute middle cerebral artery occlusion. AJNR Am J Neuroradiol 36:1266–1271CrossRefPubMed
6.
go back to reference Marder VJ, Chute DJ, Starkman S et al (2006) Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 37:2086–2093CrossRef Marder VJ, Chute DJ, Starkman S et al (2006) Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 37:2086–2093CrossRef
7.
go back to reference Niesten JM, van der Schaaf IC, van Dam L et al (2014) Histopathologic composition of cerebral thrombi of acute stroke patients is correlated with stroke subtype and thrombus attenuation. PLoS One 9:1266–1271CrossRef Niesten JM, van der Schaaf IC, van Dam L et al (2014) Histopathologic composition of cerebral thrombi of acute stroke patients is correlated with stroke subtype and thrombus attenuation. PLoS One 9:1266–1271CrossRef
8.
go back to reference Sallustio F, Koch G, Di Legge S et al (2013) Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience. J Stroke Cerebrovasc Dis 22:86–92CrossRef Sallustio F, Koch G, Di Legge S et al (2013) Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience. J Stroke Cerebrovasc Dis 22:86–92CrossRef
9.
go back to reference Simons N, Mitchell P, Dowling R, Gonzales M, Yan B (2015) Thrombus composition in acute ischemic stroke: a histopathological study of thrombus extracted by endovascular retrieval. J Neuroradiol 42:86–92CrossRef Simons N, Mitchell P, Dowling R, Gonzales M, Yan B (2015) Thrombus composition in acute ischemic stroke: a histopathological study of thrombus extracted by endovascular retrieval. J Neuroradiol 42:86–92CrossRef
10.
go back to reference Rovira A, Orellana P, Alvarez-Sabín J et al (2004) Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology 232:466–473CrossRefPubMed Rovira A, Orellana P, Alvarez-Sabín J et al (2004) Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology 232:466–473CrossRefPubMed
11.
go back to reference Bourcier R, Détraz L, Serfaty JM et al (2017) MRI Interscanner agreement of the association between the susceptibility vessel sign and histologic composition of thrombi. J Neuroimaging 27:577–582CrossRefPubMed Bourcier R, Détraz L, Serfaty JM et al (2017) MRI Interscanner agreement of the association between the susceptibility vessel sign and histologic composition of thrombi. J Neuroimaging 27:577–582CrossRefPubMed
12.
go back to reference Naggara O, Raymond J, Domingo Ayllon M et al (2013) T2* “susceptibility vessel sign” demonstrates clot location and length in acute ischemic stroke. PLoS One 8:1001–1005CrossRef Naggara O, Raymond J, Domingo Ayllon M et al (2013) T2* “susceptibility vessel sign” demonstrates clot location and length in acute ischemic stroke. PLoS One 8:1001–1005CrossRef
13.
go back to reference Aoki J, Kimura K, Shibazaki K, Sakamoto Y, Saji N, Uemura J (2013) Location of the susceptibility vessel sign on T2*-weighted MRI and early recanalization within 1 hour after tissue plasminogen activator administration. Cerebrovasc Dis Extra 3:111–120CrossRefPubMedPubMedCentral Aoki J, Kimura K, Shibazaki K, Sakamoto Y, Saji N, Uemura J (2013) Location of the susceptibility vessel sign on T2*-weighted MRI and early recanalization within 1 hour after tissue plasminogen activator administration. Cerebrovasc Dis Extra 3:111–120CrossRefPubMedPubMedCentral
14.
go back to reference Bourcier R, Volpi S, Guyomarch B et al (2015) Susceptibility vessel sign on MRI predicts favorable clinical outcome in patients with anterior circulation acute stroke treated with mechanical thrombectomy. AJNR Am J Neuroradiol 36:2346–2353CrossRefPubMed Bourcier R, Volpi S, Guyomarch B et al (2015) Susceptibility vessel sign on MRI predicts favorable clinical outcome in patients with anterior circulation acute stroke treated with mechanical thrombectomy. AJNR Am J Neuroradiol 36:2346–2353CrossRefPubMed
15.
go back to reference Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW (2005) Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 36:2379–2383 Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW (2005) Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 36:2379–2383
16.
go back to reference Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S (2005) Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 26:618–624 Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S (2005) Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 26:618–624
17.
go back to reference Soize S, Batista AL, Rodriguez Regent C et al (2015) Susceptibility vessel sign on T2* magnetic resonance imaging and recanalization results of mechanical thrombectomy with stent retrievers: a multicentre cohort study. Eur J Neurol 22:967–972CrossRef Soize S, Batista AL, Rodriguez Regent C et al (2015) Susceptibility vessel sign on T2* magnetic resonance imaging and recanalization results of mechanical thrombectomy with stent retrievers: a multicentre cohort study. Eur J Neurol 22:967–972CrossRef
18.
go back to reference Bourcier R, Derraz I, Delasalle B et al (2018) Susceptibility vessel sign and cardioembolic etiology in the THRACE trial. Clin Neuroradiol 8:1001–1005 Bourcier R, Derraz I, Delasalle B et al (2018) Susceptibility vessel sign and cardioembolic etiology in the THRACE trial. Clin Neuroradiol 8:1001–1005
19.
go back to reference Zhang R, Zhou Y, Liu C et al (2017) Overestimation of susceptibility vessel sign: a predictive marker of stroke cause. Stroke 48:1993–1996CrossRefPubMed Zhang R, Zhou Y, Liu C et al (2017) Overestimation of susceptibility vessel sign: a predictive marker of stroke cause. Stroke 48:1993–1996CrossRefPubMed
20.
go back to reference Yamamoto N, Satomi J, Tada Y et al (2015) Two-layered susceptibility vessel sign on 3-tesla T2*-weighted imaging is a predictive biomarker of stroke subtype. Stroke 46:269–271CrossRefPubMed Yamamoto N, Satomi J, Tada Y et al (2015) Two-layered susceptibility vessel sign on 3-tesla T2*-weighted imaging is a predictive biomarker of stroke subtype. Stroke 46:269–271CrossRefPubMed
21.
go back to reference Yan S, Chen Q, Zhang X et al (2016) Extensive blooming artifact predicts no recanalization after intravenous thrombolysis. Eur J Neurol 23:737–743CrossRefPubMed Yan S, Chen Q, Zhang X et al (2016) Extensive blooming artifact predicts no recanalization after intravenous thrombolysis. Eur J Neurol 23:737–743CrossRefPubMed
22.
go back to reference Hodel J, Rodallec M, Gerber S et al (2012) Susceptibility weighted magnetic resonance sequences “SWAN, SWI and VenoBOLD”: technical aspects and clinical applications. J Neuroradiol 39:71–86CrossRefPubMed Hodel J, Rodallec M, Gerber S et al (2012) Susceptibility weighted magnetic resonance sequences “SWAN, SWI and VenoBOLD”: technical aspects and clinical applications. J Neuroradiol 39:71–86CrossRefPubMed
23.
go back to reference Bracard S, Ducrocq X, Mas JL et al (2016) Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 15:1138–1147CrossRef Bracard S, Ducrocq X, Mas JL et al (2016) Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 15:1138–1147CrossRef
24.
go back to reference Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35–41 Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35–41
25.
go back to reference European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25:457–507CrossRef European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25:457–507CrossRef
26.
go back to reference Cho KY, Miyoshi H, Kuroda S et al (2013) The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. J Stroke Cerebrovasc Dis 22:910–918CrossRefPubMed Cho KY, Miyoshi H, Kuroda S et al (2013) The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. J Stroke Cerebrovasc Dis 22:910–918CrossRefPubMed
27.
go back to reference Shaikh S, Brittenden J, Lahiri R, Brown PA, Thies F, Wilson HM (2012) Macrophage subtypes in symptomatic carotid artery and femoral artery plaques. Eur J Vasc Endovasc Surg 44:491–497CrossRefPubMed Shaikh S, Brittenden J, Lahiri R, Brown PA, Thies F, Wilson HM (2012) Macrophage subtypes in symptomatic carotid artery and femoral artery plaques. Eur J Vasc Endovasc Surg 44:491–497CrossRefPubMed
28.
go back to reference Nosaka M, Ishida Y, Kimura A, Kondo T (2010) Time-dependent organic changes of intravenous thrombi in stasis-induced deep vein thrombosis model and its application to thrombus age determination. Forensic Sci Int 195:143–147CrossRefPubMed Nosaka M, Ishida Y, Kimura A, Kondo T (2010) Time-dependent organic changes of intravenous thrombi in stasis-induced deep vein thrombosis model and its application to thrombus age determination. Forensic Sci Int 195:143–147CrossRefPubMed
29.
go back to reference Park MG, Oh SJ, Baik SK, Jung DS, Park KP (2016) Susceptibility-weighted imaging for detection of thrombus in acute cardioembolic stroke. J Stroke 18:73–79 Park MG, Oh SJ, Baik SK, Jung DS, Park KP (2016) Susceptibility-weighted imaging for detection of thrombus in acute cardioembolic stroke. J Stroke 18:73–79
30.
go back to reference Emeriau S, Serre I, Toubas O, Pombourcq F, Oppenheim C, Pierot L (2013) Can diffusion-weighted imaging-fluid-attenuated inversion recovery mismatch (positive diffusion-weighted imaging/negative fluid-attenuated inversion recovery) at 3 Tesla identify patients with stroke at <4.5 hours? Stroke 44:1647–1651CrossRefPubMed Emeriau S, Serre I, Toubas O, Pombourcq F, Oppenheim C, Pierot L (2013) Can diffusion-weighted imaging-fluid-attenuated inversion recovery mismatch (positive diffusion-weighted imaging/negative fluid-attenuated inversion recovery) at 3 Tesla identify patients with stroke at <4.5 hours? Stroke 44:1647–1651CrossRefPubMed
31.
go back to reference Yan S, Liu K, Tong L, Yu Y, Zhang S, Lou M (2016) Different risk factors for poor outcome between patients with positive and negative susceptibility vessel sign. J Neurointerv Surg 8:1001–1005CrossRefPubMed Yan S, Liu K, Tong L, Yu Y, Zhang S, Lou M (2016) Different risk factors for poor outcome between patients with positive and negative susceptibility vessel sign. J Neurointerv Surg 8:1001–1005CrossRefPubMed
32.
go back to reference Nielsen VG, Kirklin JK, Holman WL, Steenwyk BL (2009) Clot lifespan model analysis of the effects of warfarin on thrombus growth and fibrinolysis: role of contact protein and tissue factor initiation. ASAIO J 55:33–40CrossRefPubMed Nielsen VG, Kirklin JK, Holman WL, Steenwyk BL (2009) Clot lifespan model analysis of the effects of warfarin on thrombus growth and fibrinolysis: role of contact protein and tissue factor initiation. ASAIO J 55:33–40CrossRefPubMed
Metadata
Title
Validation of overestimation ratio and TL-SVS as imaging biomarker of cardioembolic stroke and time from onset to MRI
Authors
Romain Bourcier
Laurence Legrand
Sébastien Soize
Julien Labreuche
Marine Beaumont
Hubert Desal
Imad Derraz
Serge Bracard
Catherine Oppenheim
Olivier Naggara
on behalf of the THRACE investigators
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 5/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5835-y

Other articles of this Issue 5/2019

European Radiology 5/2019 Go to the issue